Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Mesothelioma Cancer treatment details. Chemotherapy. University of Chicago, Chicago, IL, United States



Survival: 9.3 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs: Camptosar
Country: United States
   
City/State/Province: Chicago, IL
   
Hospital: University of Chicago
   
Journal: Link
   
Date: 6/2005

Description:
Patients: This Phase II study involved 28 patients with malignant mesothelioma. Eighteen patients were men, and ten were women. The median age was 66 years. Twenty patients had been exposed to asbestos, and fifteen had been exposed to tobacco products.

Treatment: The treatment consisted of one chemotherapeutic agent: irinotecan.

Toxicities: Three patients died of treatment related toxicities. In addition, grade 3-4 toxicities included: lymphocytopenia, granulocytopenia, leukocytopenia, diarrhea, nausea, and anorexia.

Results: The median survival was 9.3 months. The authors concluded, "Single-agent irinotecan in this dose and schedule has considerable toxicity in patients with malignant mesothelioma and has no anti-tumor activity."

Correspondence: Hedy L. Kindler, MD

E-mail to a Friend Email Physician More Information